Continuous measurement of blood pressure and blood glucose by a wearable vital sign system using FBG censer and verification of its mechanism.

Continuous measurement of blood pressure and blood glucose by a wearable vital sign system using FBG censer and verification of its mechanism. - Continuous measure of blood pressure and glucose by FBG censer.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033845

Enrollment

100

Registered

2018-08-25

Start date

2020-12-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension and diabetes mellitus

Interventions

Continuous blood pressure monitor using a CNAP 500. Continuous subcutaneous glucose monitor using iPro2.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteer and the relatively stable patients with hypertension and diabetes mellitus who are admitted to Shinshu University Hospital and obtained informed consent.

Exclusion criteria

Exclusion criteria: Subjects having chronic atrial fibrillation, severe arrhythmia, peripheral circulatory failure such as Raynaud's disease, severe deformed nail, and are judged as inappropriate by chief researcher.

Design outcomes

Primary

Measure	Time frame
Pulse wave form detected by a FBG (fiber bragg grating fiber) censor	—

Secondary

Measure	Time frame
Blood pressure value, concentration of subcutaneous glucose, ulutrasound echo image of cervical artery	—

Countries

Japan

Contacts

Public ContactHiroaki Ishizawa

Shinshu University Institute for Fiber Engineering

zawa@shinshu-u.ac.jp+81-268-21-5603

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026